Congenital Epulis: A Rare Benign Jaw Tumour in a 2-Day-Old Male Baby

Por Bhoil, Rohan, Bhoil, Rohit, Chopra, Rajesh, Sharma, Manika, Mistry, Kewal
Publicado no Pol J Radiol (2015)

The Pharmacodynamic Impact of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, on Circulating Levels of Inflammatory Biomarkers in Patients with Psoriatic Arthritis: Substudy Res...

Por Schafer, Peter H., Chen, Peng, Fang, Lorraine, Wang, Andrew, Chopra, Rajesh
Publicado no J Immunol Res (2015)

Cystic pulmonary hydatidosis

Por Sarkar, Malay, Pathania, Rajnish, Jhobta, Anupam, Thakur, Babu Ram, Chopra, Rajesh
Publicado no Lung India (2016)

Pharmacokinetics and pharmacodynamics of nab-paclitaxel in patients with solid tumors: Disposition kinetics and pharmacology distinct from solvent-based paclitaxel

Por Chen, Nianhang, Li, Yan, Ye, Ying, Palmisano, Maria, Chopra, Rajesh, Zhou, Simon
Publicado no J Clin Pharmacol (2014)

Lenalidomide augments actin remodeling and lowers NK-cell activation thresholds

Por Lagrue, Kathryn, Carisey, Alex, Morgan, David J., Chopra, Rajesh, Davis, Daniel M.
Publicado no Blood (2015)

Evaluation of MR Spectroscopy and Diffusion-Weighted MRI in Postmenopausal Bone Strength

Por Agrawal, Kanhaiya, Agarwal, Yatish, Chopra, Rajesh K, Batra, Achla, Chandra, Ranjan, Thukral, Brij B
Publicado no Cureus (2015)

Immunomodulatory Effects in a Phase II Study of Lenalidomide Combined with Cetuximab in Refractory KRAS-Mutant Metastatic Colorectal Cancer Patients

Por Gandhi, Anita K., Shi, Tao, Li, Mingyu, Jungnelius, Ulf, Romano, Alfredo, Tabernero, Josep, Siena, Salvatore, Schafer, Peter H., Chopra, Rajesh
Publicado em 2013

An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin

Por Carrancio, Soraya, Markovics, Jennifer, Wong, Piu, Leisten, Jim, Castiglioni, Paola, Groza, Matthew C, Raymon, Heather K, Heise, Carla, Daniel, Tom, Chopra, Rajesh, Sung, Victoria
Publicado no Br J Haematol (2014)

Differential effects of lenalidomide during plasma cell differentiation

Por Jourdan, Michel, Cren, Maïlys, Schafer, Peter, Robert, Nicolas, Duperray, Christophe, Vincent, Laure, Ceballos, Patrice, Cartron, Guillaume, Rossi, Jean-François, Moreaux, Jérôme, Chopra, Rajesh, Klein, Bernard
Publicado no Oncotarget (2016)

A Dual Color Immunohistochemistry Assay for Measurement of Cereblon in Multiple Myeloma Patient Samples

Por Ren, Yan, Wang, Maria, Couto, Suzana, Hansel, Donna E., Miller, Karen, Lopez-Girona, Antonia, Bjorklund, Chad C., Gandhi, Anita K., Thakurta, Anjan, Chopra, Rajesh, Breider, Michael
Publicado no Appl Immunohistochem Mol Morphol (2016)

Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration

Por Chen, Nianhang, Brachmann, Carrie, Liu, Xiping, Pierce, Daniel W., Dey, Joyoti, Kerwin, William S., Li, Yan, Zhou, Simon, Hou, Shihe, Carleton, Michael, Klinghoffer, Richard A., Palmisano, Maria, Chopra, Rajesh
Publicado no Cancer Chemother Pharmacol (2015)

Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase...

Por Gandhi, Anita K, Kang, Jian, Havens, Courtney G, Conklin, Thomas, Ning, Yuhong, Wu, Lei, Ito, Takumi, Ando, Hideki, Waldman, Michelle F, Thakurta, Anjan, Klippel, Anke, Handa, Hiroshi, Daniel, Thomas O, Schafer, Peter H, Chopra, Rajesh
Publicado no Br J Haematol (2014)

A phase I dose‐escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC‐223 in patients with advanc...

Por Bendell, Johanna C., Kelley, Robin K., Shih, Kent C., Grabowsky, Jennifer A., Bergsland, Emily, Jones, Suzanne, Martin, Thomas, Infante, Jeffrey R., Mischel, Paul S., Matsutani, Tomoo, Xu, Shuichan, Wong, Lilly, Liu, Yong, Wu, Xiaoling, Mortensen, Deborah S., Chopra, Rajesh, Hege, Kristen, Munster, Pamela N.
Publicado no Cancer (2015)

Measuring cereblon as a biomarker of response or resistance to lenalidomide and pomalidomide requires use of standardized reagents and understanding of gene complexity

Por Gandhi, Anita K, Mendy, Derek, Waldman, Michelle, Chen, Gengxin, Rychak, Emily, Miller, Karen, Gaidarova, Svetlana, Ren, Yan, Wang, Maria, Breider, Michael, Carmel, Gilles, Mahmoudi, Afshin, Jackson, Pilgrim, Abbasian, Mahan, Cathers, Brian E, Schafer, Peter H, Daniel, Tom O, Lopez-Girona, Antonia, Thakurta, Anjan, Chopra, Rajesh
Publicado no Br J Haematol (2014)

Single cell phosphoproteomics resolves adaptive signaling dynamics and informs targeted combination therapy in glioblastoma

Por Wei, Wei, Shin, Young Shik, Xue, Min, Matsutani, Tomoo, Masui, Kenta, Yang, Huijun, Ikegami, Shiro, Gu, Yuchao, Ken, Herrmann, Johnson, Dazy, Ding, Xiangming, Hwang, Kiwook, Kim, Jungwoo, Zhou, Jian, Su, Yapeng, Li, Xinmin, Bonetti, Bruno, Chopra, Rajesh, James, C. David, Cavenee, Webster K., Cloughesy, Timothy F., Mischel, Paul S., Heath, James R., Gini, Beatrice
Publicado no Cancer Cell (2016)

JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers

Por van der Velden, Jos L. J., Ye, Ying, Nolin, James D., Hoffman, Sidra M., Chapman, David G., Lahue, Karolyn G., Abdalla, Sarah, Chen, Peng, Liu, Yong, Bennett, Brydon, Khalil, Nasreen, Sutherland, Donna, Smith, William, Horan, Gerald, Assaf, Mahmoud, Horowitz, Zebulun, Chopra, Rajesh, Stevens, Randall M., Palmisano, Maria, Janssen-Heininger, Yvonne M. W., Schafer, Peter H.
Publicado no Clin Transl Med (2016)

Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS

Por Krönke, Jan, Fink, Emma C., Hollenbach, Paul W., MacBeth, Kyle J., Hurst, Slater N., Udeshi, Namrata D., Chamberlain, Philip P., Mani, D.R., Man, Hon Wah, Gandhi, Anita K., Svinkina, Tanya, Schneider, Rebekka K., McConkey, Marie, Järås, Marcus, Griffiths, Elizabeth, Wetzler, Meir, Bullinger, Lars, Cathers, Brian E., Carr, Steven A., Chopra, Rajesh, Ebert, Benjamin L.
Publicado no Nature (2015)

The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomas

Por Gini, Beatrice, Zanca, Ciro, Guo, Deliang, Matsutani, Tomoo, Masui, Kenta, Ikegami, Shiro, Yang, Huijun, Nathanson, David, Villa, Genaro R., Shackelford, David, Zhu, Shaojun, Tanaka, Kazuhiro, Babic, Ivan, Akhavan, David, Lin, Kelly, Assuncao, Alvaro, Gu, Yuchao, Bonetti, Bruno, Mortensen, Deborah S., Xu, Shuichan, Raymon, Heather K., Cavenee, Webster K., Furnari, Frank B, James, David, Kroemer, Guido, Heath, James, Hege, Kristen, Chopra, Rajesh, Cloughesy, Timothy, Mischel, Paul S.
Publicado em 2013

CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL

Por Hagner, Patrick R., Man, Hon-Wah, Fontanillo, Celia, Wang, Maria, Couto, Suzana, Breider, Mike, Bjorklund, Chad, Havens, Courtney G., Lu, Gang, Rychak, Emily, Raymon, Heather, Narla, Rama Krishna, Barnes, Leo, Khambatta, Gody, Chiu, Hsiling, Kosek, Jolanta, Kang, Jian, Amantangelo, Michael D., Waldman, Michelle, Lopez-Girona, Antonia, Cai, Ti, Pourdehnad, Michael, Trotter, Matthew, Daniel, Thomas O., Schafer, Peter H., Klippel, Anke, Thakurta, Anjan, Chopra, Rajesh, Gandhi, Anita K.
Publicado no Blood (2015)

A technology platform to assess multiple cancer agents simultaneously within a patient's tumor

Por Klinghoffer, Richard A., Bahrami, S. Bahram, Hatton, Beryl A., Frazier, Jason P., Moreno-Gonzalez, Alicia, Strand, Andrew D., Kerwin, William S., Casalini, Joseph R., Thirstrup, Derek J., You, Sheng, Morris, Shelli M., Watts, Korashon L., Veiseh, Mandana, Grenley, Marc O., Tretyak, Ilona, Dey, Joyoti, Carleton, Michael, Beirne, Emily, Pedro, Kyle D., Ditzler, Sally H., Girard, Emily J., Deckwerth, Thomas L., Bertout, Jessica A., Meleo, Karri A., Filvaroff, Ellen H., Chopra, Rajesh, Press, Oliver W., Olson, James M.
Publicado no Sci Transl Med (2015)